SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 219 filers reported holding SEATTLE GENETICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $259,000 | -33.4% | 4,760 | -36.7% | 0.03% | -40.4% |
Q2 2017 | $389,000 | -26.0% | 7,525 | -10.0% | 0.05% | -27.7% |
Q1 2017 | $526,000 | +18.5% | 8,365 | -0.5% | 0.06% | -17.7% |
Q4 2016 | $444,000 | -2.2% | 8,410 | 0.0% | 0.08% | -26.2% |
Q3 2016 | $454,000 | +32.7% | 8,410 | -0.6% | 0.11% | +24.4% |
Q2 2016 | $342,000 | +14.0% | 8,460 | -1.2% | 0.09% | -11.3% |
Q1 2016 | $300,000 | – | 8,560 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |